Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Jan van Ginkel

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
American Heart Journal|December 14, 2024
Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: Rationale and design of the PRO-TAVI trialHugo M Aarts, Kimberley I Hemelrijk, Gijs M Broeze, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2022
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2Andrea Scotti, Matteo Pagnesi, Won-Keun Kim, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 22, 2023
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trialDirk Jan van Ginkel, Willem L Bor, Christophe L F Dubois, et al.
The New England Journal of Medicine|August 31, 2024
Continuation versus Interruption of Oral Anticoagulation during TAVIDirk Jan van Ginkel, Willem L Bor, Hugo M Aarts, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulationDaniël C Overduin, Dirk Jan van Ginkel, Willem L Bor, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
American Heart Journal|December 14, 2024
Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: Rationale and design of the PRO-TAVI trialHugo M Aarts, Kimberley I Hemelrijk, Gijs M Broeze, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 9, 2022
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2Andrea Scotti, Matteo Pagnesi, Won-Keun Kim, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 22, 2023
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trialDirk Jan van Ginkel, Willem L Bor, Christophe L F Dubois, et al.
The New England Journal of Medicine|August 31, 2024
Continuation versus Interruption of Oral Anticoagulation during TAVIDirk Jan van Ginkel, Willem L Bor, Hugo M Aarts, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2025
VARC-HBR criteria validation in TAVI patients on oral anticoagulationDaniël C Overduin, Dirk Jan van Ginkel, Willem L Bor, et al.
Pageof 3